The Senate approved the House version of a spending bill for fiscal 2017 in a 79-18 vote — including a modest increase in FDA funds through September. The president signed the bill into law quickly.

Total FDA funding for the remainder of fiscal 2017 tops $4.65 billion, up 2.4 percent from the previous fiscal year.

Congress will also permit the agency to collect $1.23 billion in user fees for fiscal 2017. A Senate committee is working on the FDA user fee reauthorization bill this week.

Under the spending bill, CDER receives $1.33 billion in appropriations for fiscal 2017, with $339.6 million for CBER, and $428 million for CDRH, as well as $284 million for other FDA activities.